Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000135

Chief Medical Officer sold 2,478 shares at $22.60 ($56,003)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ho Carole Chief Medical Officer 2023-08-21 Sale −2,478 $22.60 $56,003 185,331 I
Open-market sales · 2,478 sh · avg $22.60 · $56,003
Loading xslF345X05/wk-form4_1692822872.xml…